|Articles|April 1, 2004

Automated analysis aids MHP evaluation

Washington - Researchers have discovered an algorithm that could provide a consistent tool for analyzing cases of mottled hyperpigmentation (MHP) based on photographic images.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe

Related Content

Understanding Immunologic Pathways Builds Clinician Confidence

ByEileen Cheever, MPAS, PA-C,Shannon Heaning, Content Associate

August 10th 2026

Are Private Dermatology Practices at Risk for Extinction? A New Survey Sheds Light

By Ashwin Krishnan,Shannon Heaning, Content Associate

June 30th 2026

The New Economics of Dermatology Claims: Understanding and Responding to Rising Denials

By Ashwin Krishnan,Matthew J. Elias, DO

June 23rd 2026

Contracts: The Most Important Document Most Clinicians Treat Like an Afterthought

ByJoseph Gatti, DMSc, MPAS, MBA, PA-C

May 28th 2026

Inside the Mind of NP and PA Candidates: What Employers Often Miss

ByJoseph Gatti, DMSc, MPAS, MBA, PA-C

April 3rd 2026

Latest CME

Video

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Video

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Multimedia

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Adaptive Learning

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

Automated analysis aids MHP evaluation

Related Content

Understanding Immunologic Pathways Builds Clinician Confidence

Are Private Dermatology Practices at Risk for Extinction? A New Survey Sheds Light

The New Economics of Dermatology Claims: Understanding and Responding to Rising Denials

Contracts: The Most Important Document Most Clinicians Treat Like an Afterthought

Inside the Mind of NP and PA Candidates: What Employers Often Miss

Latest CME

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Trending on Dermatology Times

Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension

Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease

Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine

Case Report Highlights Rural Care Gaps in Recurrent Merkel Cell Carcinoma

Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial